학술논문

Effectiveness and Safety of Nonmedical Switch from Adalimumab Originator to SB5 Biosimilar in Patients with Inflammatory Bowel Diseases: Twelve-Month Follow-Up from the TABLET Registry

Document Type

Article

Author

Tapete, G.; Bertani, L.; Mumolo, M.G.; Ceccarelli, L.; Costa, F.; Maltinti, S.; Pieraccini, A.; Lynch, E.N.; Bagnoli, S.; Milla, M.; Giannotta, M.; De Nigris, F.; Morganti, R.; Biviano, I.; Rentini, S.; Naldini, S.; Lionetti, P.; Calella, F.; Minciotti, M.

Source

In: Inflammatory Bowel Diseases. (Inflammatory Bowel Diseases, 1 January 2022, 28(1):62-69)

Subject

Language

English

ISSN

15364844
10780998

Online Access

Full Text (Oxford University Press) Full Text (LWW total - Ovid) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송